| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.62B | +1.3% |
| Cost of Revenue | $735.7M | +0.9% |
| R&D Expense | $472.3M | +22.1% |
| SG&A Expense | $332.4M | +2.8% |
| Operating Income | $471.4M | -16.2% |
| Interest Expense | $117.5M | -21.2% |
| Income Tax | $85.5M | -14.4% |
| Net Income | $275.3M | -10.8% |
| EPS (Basic) | $0.69 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $768.7M | -24.4% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $141.1M | -1.8% |
| Current Assets | $1.02B | -23.3% |
| Total Assets | $2.70B | -3.8% |
| Current Liabilities | $461.8M | -18.9% |
| Long-term Debt | $2.41B | -0.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $493.7M | -10.5% |
| Capital Expenditures | $68.3M | +44.1% |
| Investing Cash Flow | -$74.6M | +87.8% |
| Financing Cash Flow | -$652.0M | -216.5% |
| Free Cash Flow | $425.4M | -15.6% |
| -8.0% |
| EPS (Diluted) | $0.69 | -8.0% |
| Total Liabilities |
| $3.27B |
| +2.7% |
| Stockholders' Equity | -$568.6M | -50.5% |